![]() |
|
|
Vol. 286, Issue 2, 709-717, August 1998
DuPont Merck Research Laboratories, Central Nervous System Diseases Research, Wilmington, Delaware
| |
Abstract |
|---|
|
|
|---|
Linopirdine [DuP 996, 3,3-bis(4-pyridinylmethyl)-1-phenylindolin-2-one], a putative
cognition enhancing drug, increases acetylcholine release in rat brain
tissue and improves performance in animal models of learning and
memory. The mechanism whereby linopirdine enhances acetylcholine
release has been proposed to involve inhibition of the M-type
K+ current (IM). Our study examines the
selectivity of linopirdine for IM by determining its
effects on other ionic currents present in rat hippocampal
CA1 neurons using patch clamp techniques. Linopirdine was
found to block voltage-gated, calcium-activated and leak K+
currents in a dose-dependent manner. Of the seven currents measured, linopirdine was most selective for IM with an
IC50 of 2.4 ± 0.4 µM, followed by IC
(measured as a medium afterhyperpolarization tail current,
ImAHP) with an IC50 of 16.3 ± 2.4 µM.
Both IM and IC were completely suppressed by
linopirdine. At a concentration of 100 µM, linopirdine weakly
inhibited the K+ leak current, IL, the
transient outward current, IA, the delayed rectifier,
IK, and the slow component of IAHP, by 28 ± 8, 37 ± 10, 36 ± 9 and 52 ± 10 percent,
respectively. The mixed Na+/K+ inward
rectifying current, IQ, was essentially unaffected by linopirdine (IC50 >300 µM). These results indicate that
linopirdine selectively blocks IM at concentrations
3 µM, the approximate EC50 for acetylcholine release
enhancement. Inhibition of other voltage-gated and calcium-activated
K+ currents could also contribute to enhanced
neurotransmitter release by linopirdine at intermediate
(IC) and high (IL, IA,
IK, IsAHP) concentrations.
| |
Introduction |
|---|
|
|
|---|
Linopirdine is a
putative cognitive enhancing drug that increases stimulus-evoked
release of a number of neurotransmitters, including ACh (Nickolson
et al., 1990
; Zaczek et al., 1995
; Aiken et
al., 1996
). Although the exact mechanism by which linopirdine enhances ACh release is unknown, Maciag et al. (1994)
showed
that its effects were insensitive to 4-aminopyridine, atropine and Na+, Cl
and
Ca++ channel antagonists. In addition, they found
no apparent role for cholinergic autoreceptors. TEA was found to have
actions similar to linopirdine on ACh release suggesting the
involvement of a K+ channel in the action of
linopirdine. Recently, Aiken et al. (1995)
demonstrated that
linopirdine reduced spike frequency adaptation and blocked
IM in rat hippocampal CA1
neurons in vitro. Because the concentration-response curves
for IM block and ACh release have similar slopes
and IC50/EC50 values, it
has been proposed that M-current block may represent the mechanism
underlying linopirdine-induced neurotransmitter release enhancement
(Aiken et al., 1996
).
Before ascribing pharmacological relevance to its M-current blocking
activity, however, it is necessary to determine the effects of
linopirdine on other K+ channels. Many
K+ channel blockers have been shown to be
non-selective. For example, TEA blocks IC,
IK, IM,
IK(IR) and IK(ATP), 4-AP
blocks IA, ID, some types
of IK and IK(ATP) and
charybdotoxin blocks an intermediate-, as well as, the
large-conductance calcium-activated K+ channel
(Cook and Quast, 1990
; Halliwell, 1990
). Thus, there may be other
K+ channels more sensitive than the M channel to
the blocking action of linopirdine. In addition, a number of other
potassium currents have been implicated in the control of
neurotransmitter release. 4-AP and
-dendrotoxin, at concentrations
that inhibit IA, increase the release of
glutamate from guinea-pig cerebrocortical synaptosomes (Tibbs et
al., 1989
). Amoroso et al. (1990)
demonstrated enhanced release of
-aminobutyric acid by block of an adenosine
triphosphate-sensitive K+ channel in substantia
nigra, and Robitaille et al. (1993)
reported an increase in
transmitter release at the neuromuscular junction produced by block of
Ca++-gated K+ channels.
Our study was undertaken to determine the selectivity of linopirdine
for IM by determining its effects on the
voltage-gated K+ currents
IM, IA and
IK, the afterhyperpolarization currents, ImAHP and IsAHP, the leak
current, IL, and the inward rectifier, IQ, recorded from rat pyramidal
CA1 neurons in the hippocampal slice. Portions of
this work have previously been published in a preliminary form (Schnee
and Brown, 1995
).
| |
Methods |
|---|
|
|
|---|
Studies in this report were carried out in accordance with the Declaration of Helsinki and with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the National Institutes of Health (Rockville, MD).
Tissue preparation.
Pathogen-free male CD rats from Charles
River (Wilmington, MA) weighing 30 to 80 g (15-25 days old) were
anaesthetized with halothane. After decapitation, the brain was rapidly
excised (<1 min) and submerged in an ice-cold oxygenated physiological
solution. The brain was bisected and transverse slices containing the
hippocampus were prepared on a Vibratome tissue slicer. Slices were
transferred to a Perspex holding chamber filled with chilled saline and
allowed to reach room temperature (23°C). For recording, slices were
placed on a nylon mesh in a submersion-type chamber (Medical Systems, Greenvale, NY), pinned to a Sylgard base and perfused with an oxygenated physiological saline solution at room temperature at a rate
of 3 ml min
1. The physiological
solution for both dissection and recording was (mM) NaCl (127.0),
NaHCO3 (26.0), KCl (3.0),
CaCl2 (2.5), NaH2PO4 (1.25),
MgSO4 (1.0) and glucose (10.0), gassed with 5% CO2 in O2 (pH 7.35). TTX
(0.1 µM) or Cd++ (0.3 mM) were added to the
perfusion solution to block Na+ and
Ca++ currents, respectively.
Electrophysiological recording.
Microelectrodes were pulled
from borosilicate glass (1.5 mm OD/1.0 mm ID; World Precision
Instruments, Sarasota, FL) using a Sutter P-80/PC electrode puller
(Sutter Instruments, Novato, CA). Electrode resistances were 2-2.5
Mohms when filled with intracellular solution. Tight-seal (1-5 Gohm)
whole-cell voltage-clamp recordings, with access resistances of
20 Mohms, were obtained from neurons in the CA1
pyramidal cell body layer using the "blind" patch technique. Current recordings were obtained by means of an Axopatch 200A amplifier
(Axon Instruments, Foster City, CA). Signals were filtered at 5 KHz and
recorded with pClamp software (version 6.0.1, Axon Instruments). Series
resistance compensation was not used in order to minimize noise and
"ringing" of the amplifier. In preliminary studies, little
difference in current amplitudes was noted between the presence and
absence of series resistance compensation when using 2 to 2.5 Mohm
resistance electrodes. Except where stated, application time of drugs
was approximately 20 min. Internal solutions for whole cell recording
were (in mM) Kgluconate (140), KCl (10), HEPES
(N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid) (10), EGTA
(ethylene glycol-bis(
-aminoethylether)-N,N,N',N'-tetraacetic acid)
(10), MgCl2 (2.0),
CaCl2 (1.0) and MgATP (2.0), pH adjusted to 7.4 with KOH; later experiments used KMethylsulfate (140) or KAspartate
(130), KCl (10), HEPES (10), BAPTA (1,2-bis(2-aminophenoxy)ethane- N,N,N',N'-tetraacetic acid) (10), K2ATP (adenosine
5'-triphosphate, dipotassium salt) (5.0),
MgCl2 (2.0) and CaCl2
(1.0), pH adjusted to 6.7 (to avoid rundown; Brown et al.,
1989
; Cloues and Marrion, 1996
) with KOH to record
IM and pH 7.3 to record other currents.
Drugs. Linopirdine (free base) was synthesized at the DuPont Merck Pharmaceutical Company (Wilmington, DE). A stock solution in 0.1 N HCl was prepared immediately before use and added to the superfusing solution. All other chemicals were purchased from Sigma Chemical Co. (St. Louis, MO).
Data analysis. All calculated data are expressed as mean ± S.E.M. In cumulative dose-response experiments on the effect of linopirdine on IL amplitude over a range of voltage steps, a two-factor analysis of variance model (SuperANOVA, version 1.11, Abacus Concepts, Berkeley, CA) was used to test the hypothesis that mean control (pretreatment) values were unchanged with drug treatment. If there was evidence of a statistically significant treatment effect, Duncan's New Multiple Range test (SuperANOVA) was used to identify the significant dose effects. Statistical significance level was set at P < .05.
| |
Results |
|---|
|
|
|---|
Voltage-Gated Currents
IM.
M-current activates at potentials
positive to
70 mV and is fully activated at
30 mV (Brown, 1988
). To
record IM, hippocampal CA1 neurons
were stepped to
30 mV for 30 sec from a holding potential of
50 mV,
repolarized by 20 mV for 2 sec and then stepped to
30 mV for 10 sec.
Using this protocol, M-current deactivated in a mono-exponential manner
during the 20 mV repolarization step. The amplitude of
IM was measured by fitting a single exponential function (Clampfit, Axon Instruments) to the outward deactivation tail
current and extrapolating to the onset of the repolarization step. Each
measure of IM was the mean of nine repetitions of
this protocol. Time constants for current deactivation from
30 mV were in the range of 110 to 220 msec, which were comparable to previously published reports (Brown, 1988
). IM in
this preparation was sensitive to 50 µM carbachol and 1 mM
Ba++ (figs. 1A and
B) and was stable for >60 min after breaking into whole cell mode
(amplitude was 106 ± 5, 104 ± 6 and 104 ± 9% of control after 20, 40 and 60 min, respectively).
|
IA.
The transient outward potassium
current, IA, observed in these studies was
initially characterized by determining its electrophysiological and
pharmacological properties. Steady-state inactivation was studied by
applying, from a holding potential of
50 mV, 100 msec prepulses to
potentials of
20 to
110 mV followed by a 300 msec voltage step to
+50 mV. Steady state activation was examined by clamping to potentials
between
40 and +50 mV from a
50 mV holding potential in 10 mV
increments. These studies showed that >90% of
IA inactivation was removed by prepulses to
potentials more negative than
75 mV and that IA
activated positive to
30 mV (fig. 2A).
These characteristics, along with the observed block of
IA by 4-AP (fig. 2B), are consistent with known
properties of this current.
|
50 mV
and the peak of the transient current component following step
depolarization (fig. 2B). The effects of 10, 30 and 100 µM
linopirdine on 1) the voltage dependence of steady state inactivation
and activation, 2) peak current amplitude during activation (fig. 2C)
and 3) rate of inactivation were determined. Linopirdine had no effect
on either the voltage dependence of steady-state inactivation or the
voltage dependence of activation at any concentration studied.
Linopirdine did, however, significantly reduce peak
IA amplitude and tau inactivation (fig. 2D) by
37 ± 10 and 49 ± 3%, respectively, at 100 µM. These
results indicate that the effects of linopirdine on
IA were weak in comparison to its block of
IM.
IK.
The delayed rectifier current,
IK, observed in these studies was evoked by 2000 msec depolarizing steps to +60 mV from a holding potential of
50 mV
in 10 mV increments without a hyperpolarizing prepulse.
IK, measured as the steady-state current
amplitude at the end of each depolarizing step (baseline values were
5416 ± 654 pA at +60 mV; n = 13), activated at
potentials positive to
30 mV (fig. 3A)
and only slowly inactivated during the command pulse (fig. 3B). These
characteristics, along with the blocking effects of TEA (fig. 3B), are
established properties of IK.
|
Afterhyperpolarization Currents
The outward tail current recorded from hippocampal
CA1 neurons after 10 mV incremental depolarizing
steps from a holding potential of
50 mV to +60 mV in the absence of
calcium channel blockers (figs. 4A and
6B) appeared to be a composite of two currents which could be
differentiated kinetically (medium and slow) as well as
pharmacologically. Voltage steps of 3.5 to 108 msec duration to 10 to
+60 mV elicited tail currents which decayed in a biexponential manner
(figs. 4, B, C and D). The first component was not well resolved under
the experimental conditions used. Results of the second exponential fit
(as performed by the Clampex portion of pCLAMP; mixed method) were used
to measure ImAHP parameters. Maximum ImAHP amplitude (744 ± 129 pA;
n = 7) with a deactivation rate constant of 33 ± 7 msec (n = 7) was evoked by a 108 msec step to +60 mV.
The slowest tail current component (referred to as IsAHP) was activated by long (1.5 sec)
depolarizing steps to
30 mV and above (fig. 6A). Typically,
IsAHP peaked 3 to 5 sec after termination of the
depolarizing step (at an amplitude of 228 ± 45 pA;
n = 14) and deactivated over the next several seconds
(fig. 6B and C). The effect of linopirdine on
ImAHP and IsAHP was
determined using a step duration and amplitude at or near maximum for
each current component; i.e., a step to +60 mV for 54 ms for
ImAHP and 1.5 sec for
IsAHP.
|
ImAHP.
To characterize
ImAHP pharmacologically, the effects of TEA and
cobalt, inhibitors of hippocampal IC, were
evaluated. TEA (1.5 mM) was effective in reducing the amplitude of
ImAHP (by 57 ± 4.5%; n = 6) (fig. 5A) and had no effect on
IsAHP. Cobalt (2 mM) also reduced
ImAHP amplitude (72%, n = 2),
whereas cholinergic agonists (carbachol and muscarine, 5-50 µM) and
norepinephrine (3-10 µM) had no consistent effect on
ImAHP. Because ImAHP was blocked by TEA and cobalt, not blocked by carbachol and had a deactivation time constant of approximately 30 msec, it was assumed that ImAHP is largely comprised of what is
commonly referred to as IC (Storm, 1990
).
|
IsAHP.
The current underlying the slow
afterhyperpolarization in hippocampal pyramidal neurons can be blocked
by several neurotransmitters, including norepinephrine and
acetylcholine (Storm, 1990
). To verify the identity of
IsAHP as the current commonly referred to in the literature as IAHP, the effects of
norepinephrine, muscarine and TEA were evaluated. In agreement with
published reports, 10 µM norepinephrine (fig.
6B) and 10 µM muscarine markedly
attenuated IsAHP, whereas 1.5 mM TEA had no
effect on IsAHP in the same preparations in which
it blocked ImAHP by an average of 57 percent
(data not shown).
|
Inward Rectifier and Leak Current
IQ.
IQ, a mixed
Na+/K+ current, was
recorded in CA1 neurons in response to 10 mV
incremental hyperpolarizing voltage steps from a holding potential of
30 mV (fig. 7A).
IQ slowly activates (
= 241 ± 7.5 msec
at
100 mV) at potentials negative to
60 mV, is noninactivating and
is sensitive to 5 mM cesium (fig. 7B). Linopirdine, at 30 µM, had no
effect on IQ (fig. 7C) and, at concentrations as
high as 300 µM, only slightly reduced IQ (by
26%). Thus, the inwardly rectifying current examined in this study was
even less sensitive to linopirdine than were the weakly inhibited
IA, IK and
IsAHP.
|
IL.
IL, a leak
potassium current, was measured in CA1 neurons as
the instantaneous current component evoked by the voltage protocol utilized to activate IQ (fig. 7C). In agreement
with Benson et al. (1988)
, the instantaneous current was
nonrectifying over the range of
40 to
100 mV (fig. 7D). In four
cells, linopirdine induced a small, concentration-dependent reduction
of IL which was statistically significant at both
30 and 100 µM. Under control conditions, a voltage step from
30 to
100 mV induced an instantaneous current of
892 ± 108 pA which
was reduced by 9 ± 5, 17 ± 8 and 28 ± 8% in the
presence of 10, 30 and 100 µM linopirdine, respectively. These
results indicate that, like IA,
IK, IsAHP and
IQ, IL is weakly inhibited
by linopirdine.
| |
Discussion |
|---|
|
|
|---|
Our objective was to determine the selectivity of linopirdine for
IM by measuring its effects on other
voltage-dependent and calcium-activated K+
currents. The order of sensitivity to linopirdine among the seven currents recorded from hippocampal CA1 neurons
was IM > ImAHP
IK = IsAHP > IL = IA
IQ. Thus, linopirdine showed approximately seven
times more selectivity for IM than the next most
sensitive current, ImAHP, and a more than 50-fold
selectivity for IM over the other five measured
currents. In addition, IM and
ImAHP were the only K+
currents that could be completely blocked by linopirdine.
The inhibition of IM by linopirdine observed in
our study confirms previous reports on its effects in rat hippocampal
CA1 neurons (Aiken et al., 1995
) and
rat superior cervical ganglia (Lamas et al., 1997
; Costa and
Brown, 1997
). The IC50 of 2.4 µM determined in
this study agrees well with reported values in the range of 3.4 to 8.5 µM. In addition, in all four studies, linopirdine, in a concentration
range of 30 to 100 µM, inhibited IM by 100%. This, together with the lack of effect of internal GTP
S, GDP
S or
BAPTA on IM inhibition (Costa and Brown, 1997
)
and the block of M channels in outside-out membrane patches (Lamas
et al., 1997
), strongly indicate that linopirdine is a
direct M channel blocker as opposed to working through a G-protein- or
calcium-coupled second messenger system. The ability of linopirdine to
block M channels is, as previously discussed (Aiken et al.,
1995
), likely to account for its voltage-dependent depolarization of
resting membrane potential and reduction of spike frequency adaptation.
Given the putative role of IC in mediating spike
repolarization (Storm, 1990
), the block of ImAHP
(IC) observed in the present study by linopirdine
may account for its effects on action potential duration in hippocampal
CA1 neurons. In studies performed at room temperature, a single concentration of linopirdine (10 µM) had no
effect on action potential duration (Aiken et al., 1995
).
Under these conditions, action potential duration was already prolonged relative to physiologic temperature and, based on the
IC50 of 16.3 µM determined in this study,
IC inhibition was likely to be less than 50%.
However, in earlier studies performed at 37°C using a concentration
range of 5 to 100 µM (Lampe and Brown, 1991
), linopirdine exerted a
concentration-dependent prolongation of action potential duration, with
small effects (20-30% increase) noted at 10 µM and a more than
100% increase seen at 30 µM. In addition, the weak inhibition of
IA and IK observed in this
study (and by Lamas et al., 1997
in rat superior cervical
ganglia) may also contribute to the prolongation of action potential
duration exerted by
30 µM linopirdine.
In current clamp studies using sharp microelectrodes, we observed that
10 µM linopirdine had no significant effect on: 1) normal resting
membrane potential, 2) the voltage sag during a prolonged
hyperpolarizing pulse from resting potential (Lampe and Brown, 1991
)
and 3) the slow afterhyperpolarization after a train of action
potentials evoked by a prolonged depolarizing pulse (Aiken et
al., 1995
). Because these potentials can, at least in part, be
accounted for by IL, IQ and
the IsAHP, respectively, our findings of a weak
or absent effect of 10 µM linopirdine on these currents are in
agreement with the current clamp results. At
30 µM, we have seen a
depolarization of normal resting potential induced by linopirdine (B.J.
Lampe, P.A. Murphy and B.S. Brown, unpublished observation)
which may be due to its small but significant inhibition of
IL.
Using cultured rat sympathetic ganglia, Lamas et al.
(1997)
also studied the effects of linopirdine on a variety of ionic currents. In general, there is good agreement between their results and
those of our study in that linopirdine potently inhibited IM, weakly inhibited IA and
IK and, at 10 µM, had no significant effect on
IAHP or IQ. One notable
difference between the two studies, however, is the effect of
linopirdine on IC. In sympathetic ganglia, 10 µM linopirdine had no effect on IC whereas in
hippocampal CA1 neurons,
ImAHP/IC was inhibited at
an IC50 of 16.3 µM and was one of two currents
completely suppressed by linopirdine. The difference in the
pharmacology of IC between ganglia and
CA1 neurons may represent a difference in the
expression of BK channel subtypes, because the activation of BK
channels is believed to correspond to the IC
macroscopic current (Sah, 1996
). A similar explanation has been
proposed to account for the well known difference in the pharmacology
of the small-conductance, calcium-activated K+ current in
sympathetic ganglia and hippocampus (Lancaster and Adams, 1986
; Storm,
1989
; Sah, 1996
) where the ganglionic current is apamin-sensitive but
the hippocampal current is apamin-insensitive. This pharmacological
difference may be related to the expression of different SK channel
subtypes in the two tissues (Kohler et al., 1996
).Similarly,
because there are at least two major subtypes of BK channels (for
review, see Gribkoff et al., 1997
), a difference in BK
expression between sympathetic ganglia and hippocampal
CA1 neurons could explain the apparent difference
in sensitivity of IC to linopirdine in the two
cell types.
Previous studies into the mechanism whereby linopirdine enhances
neurotransmitter release indicated an inhibition of M-current as the
most likely site of action (Aiken et al., 1995
, 1996
). Our
results support this conclusion and, in addition, suggest that the
inhibition of IC may also play an important role
in the action of linopirdine because there was only a 7-fold separation between the IC50 values for the two currents.
Accordingly, both an inhibition of IC/BK channels
and the resultant action potential broadening have been associated with
enhancement of transmitter release (Robitaille et al., 1993
;
Jackson et al., 1991
). Furthermore, although the mechanism
of M-current block has been studied in some detail, with results
indicating a direct channel interaction (Lamas et al., 1997
;
Costa and Brown, 1998
), similar studies have not been performed with BK
channels. However, because most, if not all, known activators and
blockers of BK channels are direct channel blockers (Gribkoff et
al., 1997
), the same may also be true of linopirdine.
We have shown that linopirdine is a selective blocker of M-current at
concentrations below 10 µM in hippocampal CA1
neurons. At higher concentrations, it will first block
IC, then IK,
IsAHP, IL,
IA and IQ. This progression
of ion channel effects, as well as its interaction with peripheral
ligand-gated channels (Lamas et al., 1997
), must be
considered when interpreting the functional and toxicological
properties of linopirdine.
| |
Footnotes |
|---|
Accepted for publication April 10, 1998.
Received for publication November 17, 1997.
Send reprint requests to: Dr. Barry S. Brown, DuPont Pharmaceuticals Research Laboratories, P.O. Box 80400, Wilmington, DE 19880-0400.
| |
Abbreviations |
|---|
IM, M-current; IA, transient K+-current; IK, delayed rectifier K+ current; ImAHP, medium calcium-activated K+ current; IC, TEA-sensitive, large conductance calcium-activated K+ current; IsAHP, slow calcium-activated K+ current; IL, leak potassium current; IQ, slow inward rectifier Na+/K+ current; ID, slowly inactivating, highly 4-aminopyridine-sensitive, delay K+ current; IK(ATP), ATP-sensitive K+ current; ACh, acetylcholine; TEA, tetraethylammonium; 4-AP, 4-aminopyridine; TTX, tetrodotoxin.
| |
References |
|---|
|
|
|---|
Structure, Classification, Function and Therapeutic Potential (Cook NS ed) pp 181-255,
Ellis Horwood Limited, Chichester, England.
Structure, Classification, Function and Therapeutic Potential (Cook NS ed) pp 348-381,
Ellis Horwood Limited, Chichester, England.
and Na+ ion permeabilities in the acetylcholine release enhancing effects of linopirdine (DuP 996) in rat cerebral cortical slices.
J Pharmacol Exp Ther
271:
891-897
-bungarotoxin act at common loci but by two distinct mechanisms to induce Ca2+-dependent release of glutamate from guinea-pig cerebrocortical synaptosomes.
J Neurochem
52:
201-206[Medline].This article has been cited by other articles:
![]() |
V. F. Safiulina, P. Zacchi, M. Taglialatela, Y. Yaari, and E. Cherubini Low expression of Kv7/M channels facilitates intrinsic and network bursting in the developing rat hippocampus J. Physiol., November 15, 2008; 586(22): 5437 - 5453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Mackie and K. L. Byron Cardiovascular KCNQ (Kv7) Potassium Channels: Physiological Regulators and New Targets for Therapeutic Intervention Mol. Pharmacol., November 1, 2008; 74(5): 1171 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schuetz, S. Kumar, P. Poronnik, and D. J. Adams Regulation of the voltage-gated K+ channels KCNQ2/3 and KCNQ3/5 by serum- and glucocorticoid-regulated kinase-1 Am J Physiol Cell Physiol, July 1, 2008; 295(1): C73 - C80. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Power and P. Sah Competition between Calcium-Activated K+ Channels Determines Cholinergic Action on Firing Properties of Basolateral Amygdala Projection Neurons J. Neurosci., March 19, 2008; 28(12): 3209 - 3220. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen and Y. Yaari Spike Ca2+ influx upmodulates the spike afterdepolarization and bursting via intracellular inhibition of KV7/M channels J. Physiol., March 1, 2008; 586(5): 1351 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshida and A. Alonso Cell-Type Specific Modulation of Intrinsic Firing Properties and Subthreshold Membrane Oscillations by the M(Kv7)-Current in Neurons of the Entorhinal Cortex J Neurophysiol, November 1, 2007; 98(5): 2779 - 2794. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Holt, S. Chatlani, A. Lysakowski, and J. M. Goldberg Quantal and Nonquantal Transmission in Calyx-Bearing Fibers of the Turtle Posterior Crista J Neurophysiol, September 1, 2007; 98(3): 1083 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Snitsarev, C. A. Whiteis, M. W. Chapleau, and F. M. Abboud Mechano- and chemosensitivity of rat nodose neurones - selective excitatory effects of prostacyclin J. Physiol., July 1, 2007; 582(1): 177 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Crozier, S. K. Ajit, E. J. Kaftan, and M. H. Pausch MrgD Activation Inhibits KCNQ/M-Currents and Contributes to Enhanced Neuronal Excitability J. Neurosci., April 18, 2007; 27(16): 4492 - 4496. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Peretz, A. Sheinin, C. Yue, N. Degani-Katzav, G. Gibor, R. Nachman, A. Gopin, E. Tam, D. Shabat, Y. Yaari, et al. Pre- and Postsynaptic Activation of M-Channels By a Novel Opener Dampens Neuronal Firing and Transmitter Release J Neurophysiol, January 1, 2007; 97(1): 283 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lawrence, F. Saraga, J. F. Churchill, J. M. Statland, K. E. Travis, F. K. Skinner, and C. J. McBain Somatodendritic Kv7/KCNQ/M Channels Control Interspike Interval in Hippocampal Interneurons. J. Neurosci., November 22, 2006; 26(47): 12325 - 12338. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Golomb, C. Yue, and Y. Yaari Contribution of Persistent Na+ Current and M-Type K+ Current to Somatic Bursting in CA1 Pyramidal Cells: Combined Experimental and Modeling Study J Neurophysiol, October 1, 2006; 96(4): 1912 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Wladyka and D. L. Kunze KCNQ/M-currents contribute to the resting membrane potential in rat visceral sensory neurons J. Physiol., August 15, 2006; 575(1): 175 - 189. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koyama and S. B. Appel Characterization of M-Current in Ventral Tegmental Area Dopamine Neurons J Neurophysiol, August 1, 2006; 96(2): 535 - 543. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yue and Y. Yaari Axo-Somatic and Apical Dendritic Kv7/M Channels Differentially Regulate the Intrinsic Excitability of Adult Rat CA1 Pyramidal Cells J Neurophysiol, June 1, 2006; 95(6): 3480 - 3495. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Sceniak and M. B. MacIver Cellular Actions of Urethane on Rat Visual Cortical Neurons In Vitro J Neurophysiol, June 1, 2006; 95(6): 3865 - 3874. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Dzhura, W. He, and K. P. M. Currie Linopirdine Modulates Calcium Signaling and Stimulus-Secretion Coupling in Adrenal Chromaffin Cells by Targeting M-Type K+ Channels and Nicotinic Acetylcholine Receptors J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1165 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chevallier, F. Nagy, and J.-M. Cabelguen Cholinergic control of excitability of spinal motoneurones in the salamander J. Physiol., February 1, 2006; 570(3): 525 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Rennie and M. A. Streeter Voltage-Dependent Currents in Isolated Vestibular Afferent Calyx Terminals J Neurophysiol, January 1, 2006; 95(1): 26 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gu, K. Vervaeke, H. Hu, and J. F Storm |